Aptose to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 23 2025
0mins
Source: Newsfilter
Aptose Biosciences Announcement: Aptose Biosciences Inc. will participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference on May 5-6, 2025, where CEO Dr. William G. Rice will present and hold one-on-one meetings with investors.
Company Focus and Product Development: Aptose is focused on developing precision oncology therapies, particularly its lead compound tuspetinib (TUS), aimed at treating newly diagnosed acute myeloid leukemia (AML) as part of a triple drug therapy regimen.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
